Seeking Alpha

Sangamo BioScience (SGMO +5.2%) moves up after the company publishes research using zinc finger...

Sangamo BioScience (SGMO +5.2%) moves up after the company publishes research using zinc finger DNA-binding protein technology to insert a gene that will essentially "silence" the extra copy of a gene that causes Downs Syndrome. The procedure provides a model for studing the basic biology of Down syndrom, and could enable the development of drugs that can potentially rebalance the cellular processes and pathologies that are affected by the disorder.
Comments (1)
  • Director one
    , contributor
    Comments (59) | Send Message
     
    Great science...........it will take 7 years to get thru FDA.......
    17 Jul 2013, 04:25 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|